{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:23:34Z","timestamp":1791779014054,"version":"4.3.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/mbc.0b013e328363b147","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T04:56:00Z","timestamp":1379652960000},"page":"749-756","source":"Crossref","is-referenced-by-count":24,"title":["Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia"],"prefix":"10.1097","volume":"24","author":[{"given":"Susanna","family":"Ranta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats M.","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervi","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla M.","family":"Saarinen-Pihkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Frisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.-T.","family":"M\u00e4kipernaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.1995.tb00699.x","article-title":"Effects of Erwinia-asparaginase on the coagulation system.","volume":"55","author":"Carlsson","year":"1995","journal-title":"Eur J Haematol"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0609.1996.tb00290.x","article-title":"Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children.","volume":"56","author":"Nowak-Gottl","year":"1996","journal-title":"Eur J Haematol"},{"key":"R3-14-20210203","first-page":"127","article-title":"Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL.","volume":"81","author":"Nowak-Gottl","year":"1996","journal-title":"Haematologica"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1996.d01-1873.x","article-title":"Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation.","volume":"95","author":"Nowak-Gottl","year":"1996","journal-title":"Br J Haematol"},{"key":"R5-14-20210203","first-page":"120","article-title":"Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.","volume":"16","author":"Mitchell","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-2007-1000660","article-title":"Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment.","volume":"21","author":"Mitchell","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood.V99.8.2734","article-title":"Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Childrens Leukemia Group phase 3 trial.","volume":"99","author":"Duval","year":"2002","journal-title":"Blood"},{"key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in LAsparaginase-induced antithrombin III deficiency.","volume":"83","author":"Mitchell","year":"1994","journal-title":"Blood"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.","volume":"97","author":"Silverman","year":"2001","journal-title":"Blood"},{"key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/leu.2008.165","article-title":"Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.","volume":"22","author":"Appel","year":"2008","journal-title":"Leukemia"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ejh.12097","article-title":"Risk group assignment differs for children and adults 1-45 years with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.","volume":"90","author":"Toft","year":"2013","journal-title":"Eur J Haematol"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1160\/TH02-11-0283","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.","volume":"90","author":"Mitchell","year":"2003","journal-title":"Thromb Haemost"},{"key":"R13-14-20210203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.21222","article-title":"Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.","volume":"50","author":"Meister","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cncr.11042","article-title":"Prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L asparaginase.","volume":"97","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"key":"R16-14-20210203","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3324\/haematol.12948","article-title":"Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.","volume":"93","author":"Hunault-Berger","year":"2008","journal-title":"Haematologica"},{"key":"R17-14-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2008-1043789","article-title":"Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.","volume":"211","author":"Mall","year":"1999","journal-title":"Klin Padiatr"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1309\/AYJPM5QWLV9KMHQV","article-title":"Antithrombin III determination in nearly-undiluted plasma.","volume":"39","author":"Stief","year":"2008","journal-title":"Lab Med"},{"key":"R19-14-20210203","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1182\/blood-2009-07-231084","article-title":"The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.","volume":"114","author":"Abbott","year":"2009","journal-title":"Blood"},{"key":"R20-14-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ajh.2830470302","article-title":"Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase.","volume":"47","author":"Halton","year":"1994","journal-title":"Am J Hematol"},{"key":"R21-14-20210203","first-page":"451","article-title":"Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy.","volume":"80","author":"Nowak-Gottl","year":"1995","journal-title":"Haematologica"},{"key":"R22-14-20210203","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2141.2007.06677.x","article-title":"Thrombosis and acute lymphoblastic leukaemia.","volume":"138","author":"Payne","year":"2007","journal-title":"Br J Haematol"},{"key":"R23-14-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0049-3848(01)00286-9","article-title":"Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginaseprednisone administration.","volume":"103","author":"Nowak-Gottl","year":"2001","journal-title":"Thromb Res"},{"key":"R24-14-20210203","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1182\/blood-2010-01-263012","article-title":"Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.","volume":"115","author":"Mitchell","year":"2010","journal-title":"Blood"},{"key":"R25-14-20210203","first-page":"303","article-title":"Asparaginase modulates thrombin generation.","volume":"1","author":"Stief","year":"2008","journal-title":"Hemostasis Lab"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e328363b147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:40Z","timestamp":1786039180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201310000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328363b147","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}